Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 29, 2024, titled "Dr. Reddy s receives positive CHMP opinion from European Medicines Agency for its proposed Rituximab biosimilar".
Dr. Reddy's Laboratories Ltd. Press Release Jul 29 2024
Filed with NSE ·
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
Dr. Reddy's Laboratories Ltd. on 6ix
Earlier from Dr. Reddy's Laboratories
- Press Release Jul 18 2024
- Press Release Jun 28 2024
- Press Release Jun 03 2024
- Press Release May 07 2024
- Press Release Jan 30 2024
Later from Dr. Reddy's Laboratories
- Press Release Oct 02 2024
- Press Release Oct 08 2024
- Press Release Oct 28 2024
- Dr. Reddy's Laboratories Ltd. Press Release Nov 28 2024
- Dr. Reddy's Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., due to Mislabeling of Infusion Bag
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories